The scope of patient, healthcare professional and healthcare systems responsibilities to reduce the carbon footprint of inhalers: a response to commentaries
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
- Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice
- Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
- Green prescribing is good, but patients do not have a duty to accept it
- Carbon footprint impact of the choice of inhalers for asthma and COPD
- Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
- Inhaler devices for asthma
- Inhalers: to switch or not to switch? That is the question
- Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
- The president speaks: prevention is best: lessons from protecting the ozone layer